.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Novartis
Chubb
Cantor Fitzgerald
Queensland Health
Healthtrust
Merck
Accenture
McKinsey

Generated: June 22, 2017

DrugPatentWatch Database Preview

Cefamandole nafate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cefamandole nafate and what is the scope of cefamandole nafate freedom to operate?

Cefamandole nafate
is the generic ingredient in one branded drug marketed by Lilly and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for cefamandole nafate.

Summary for Generic Name: cefamandole nafate

Tradenames:1
Patents:1
Applicants:1
NDAs:2
Drug Master File Entries: see list5
Bulk Api Vendors: see list39
Clinical Trials: see list1
Patent Applications: see list1,327
Therapeutic Class:Antibacterials
Drug Prices:see low prices
DailyMed Link:cefamandole nafate at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
MANDOL
cefamandole nafate
INJECTABLE;INJECTION050504-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
MANDOL
cefamandole nafate
INJECTABLE;INJECTION050504-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lilly
MANDOL
cefamandole nafate
INJECTABLE;INJECTION062560-002Sep 10, 1985DISCNNoNo► Subscribe► Subscribe
Lilly
MANDOL
cefamandole nafate
INJECTABLE;INJECTION062560-001Sep 10, 1985DISCNNoNo► Subscribe► Subscribe
Lilly
MANDOL
cefamandole nafate
INJECTABLE;INJECTION050504-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Citi
McKesson
Fish and Richardson
Accenture
Cerilliant
Moodys
Express Scripts
Boehringer Ingelheim
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot